Search research articles
Contact Us
Filters
Showing results (11-20 of 178) with videos related to
Page
of 18
Sort By:
Journal of Bacteriology
|
November 26, 2002
Mycobacterium bovis BCG response regulator essential for hypoxic dormancy
Calvin Boon, Thomas Dick
Future Microbiology
|
March 24, 2012
How Mycobacterium tuberculosis goes to sleep: the dormancy survival regulator DosR a decade later
Calvin Boon, Thomas Dick
Progress in Biophysics and Molecular Biology
|
November 19, 2019
Targeted protein degradation in antibacterial drug discovery?
Pooja Gopal, Thomas Dick
Current Opinion in Microbiology
|
August 1, 2014
Reactive dirty fragments: implications for tuberculosis drug discovery
Pooja Gopal, Thomas Dick
American Journal of Respiratory and Critical Care Medicine
|
June 21, 2021
A Ginger Root or Plum Model for the Tuberculosis "Granuloma"?
Véronique Dartois, Thomas Dick
Msphere
|
March 21, 2017
Mycobacterial Caseinolytic Protease Gene Regulator ClgR Is a Substrate of Caseinolytic Protease
Yoshiyuki Yamada, Thomas Dick
Clinical Microbiology Reviews
|
October 3, 2024
Toward better cures for <i>Mycobacterium abscessus</i> lung disease
Véronique Dartois, Thomas Dick
Antimicrobial Agents and Chemotherapy
|
June 12, 2019
Bedaquiline Eliminates Bactericidal Activity of β-Lactams against Mycobacterium abscessus
Marissa Lindman, Thomas Dick
International Journal of Antimicrobial Agents
|
February 24, 2015
The new tuberculosis drug Perchlozone® shows cross-resistance with thiacetazone
Pooja Gopal, Thomas Dick
Molecules (Basel, Switzerland)
|
October 27, 2022
Why Matter Matters: Fast-Tracking <i>Mycobacterium abscessus</i> Drug Discovery
Uday S Ganapathy, Thomas Dick
Page
of 18
Search research articles
Search
Showing results (11-20 of 178) with videos related to
Sort By:
Page
of 18
Journal of Bacteriology
|
November 26, 2002
Mycobacterium bovis BCG response regulator essential for hypoxic dormancy
Calvin Boon, Thomas Dick
Future Microbiology
|
March 24, 2012
How Mycobacterium tuberculosis goes to sleep: the dormancy survival regulator DosR a decade later
Calvin Boon, Thomas Dick
Progress in Biophysics and Molecular Biology
|
November 19, 2019
Targeted protein degradation in antibacterial drug discovery?
Pooja Gopal, Thomas Dick
Current Opinion in Microbiology
|
August 1, 2014
Reactive dirty fragments: implications for tuberculosis drug discovery
Pooja Gopal, Thomas Dick
American Journal of Respiratory and Critical Care Medicine
|
June 21, 2021
A Ginger Root or Plum Model for the Tuberculosis "Granuloma"?
Véronique Dartois, Thomas Dick
Msphere
|
March 21, 2017
Mycobacterial Caseinolytic Protease Gene Regulator ClgR Is a Substrate of Caseinolytic Protease
Yoshiyuki Yamada, Thomas Dick
Clinical Microbiology Reviews
|
October 3, 2024
Toward better cures for <i>Mycobacterium abscessus</i> lung disease
Véronique Dartois, Thomas Dick
Antimicrobial Agents and Chemotherapy
|
June 12, 2019
Bedaquiline Eliminates Bactericidal Activity of β-Lactams against Mycobacterium abscessus
Marissa Lindman, Thomas Dick
International Journal of Antimicrobial Agents
|
February 24, 2015
The new tuberculosis drug Perchlozone® shows cross-resistance with thiacetazone
Pooja Gopal, Thomas Dick
Molecules (Basel, Switzerland)
|
October 27, 2022
Why Matter Matters: Fast-Tracking <i>Mycobacterium abscessus</i> Drug Discovery
Uday S Ganapathy, Thomas Dick
Page
of 18